Elevance Health (ELV): Baupost Group reduced its stake -50K shares
Baupost Group reduced its stake in Elevance Health, per its Q4 2025 13F.
- 1.27M
- Shares reported · -50K vs prior quarter
- 8.4%
- Disclosed portfolio weight
- $445M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 13, 2026
What stands out in this filing
- 1,319,000 shares in Q3 2025, 1,269,302 now (−3.8% in share count).
- Reported at $445M, 8.43% of the portfolio value in this 13F filing.
- 75 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 29, 2025CongressDisclosed purchase of ELV — reported range $15,001 - $50,000
- Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Feb 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 26, 2026, Elevance Health, Inc. (the “Company”) announced certain management changes. Among these changes, Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, to devote more time to family commitments.”
- Mar 5, 2026Insider · Their first buy on recordDirector purchased ~$870K of ELV shares in the open market
- Mar 6, 2026InsiderOfficer sold ~$911K of ELV shares in the open market
- Mar 12, 2026InsiderDirector sold ~$7.5K of ELV shares in the open market
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.1%
- May 19, 2026InsiderOfficer sold ~$617K of ELV shares in the open market
- Jun 11, 2026InsiderDirector sold ~$61K of ELV shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Elevance Health
For Elevance Health, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.
How this filing works
Explore the data
Common questions
What does this filing report about Elevance Health (ELV) stock?
Baupost Group reduced its stake in Elevance Health, per its Q4 2025 13F. Now 1.27M shares, $445M reported value, 8.4% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.
What stands out in this filing?
1,319,000 shares in Q3 2025, 1,269,302 now (−3.8% in share count). Reported at $445M, 8.43% of the portfolio value in this 13F filing. 75 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Elevance Health recently?
For Elevance Health, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ELV page.
Does this mean ELV stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Elevance Health
- SEC Form 4Nov 20, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 4Oct 23, 2026
- SEC Form 4Oct 23, 2026
Everything OQRO holds on this company is on its ELV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
